COLOMBIA WOLFF: Open Payments
NPI 1083102933 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 13 payments from 10 companies in 2025. Trend: 2023 $728 · 2024 $1,077 · 2025 $408
Food & beverage: $315Education: $93
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $114 |
| Janssen Biotech, Inc. | 1 | $75 |
| ABBVIE INC. | 3 | $58 |
| Ardelyx, Inc. | 1 | $53 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Celltrion USA Inc. | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: Livdelzi, STELARA, IBSRELA, RINVOQ, IQIRVO, XIFAXAN, VEGZELMA, SKYRIZI.
Industry payments across IA — which companies pay providers there.
